Orthobiologics Market
According to Intent Market Research, the Orthobiologics Market is expected to grow from USD 10.0 billion in 2024-e at a CAGR of 12.4% to touch USD 20.2 billion by 2030. The Orthobiologics Market is dominated by key players such as, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Anika Therapeutics, Inc., and Mitek Sports Medicine.